Valneva Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Valneva's estimated annual revenue is currently $109.9M per year.(i)
  • Valneva's estimated revenue per employee is $146,170
  • Valneva's current valuation is $2B. (January 2022)

Employee Data

  • Valneva has 752 Employees.(i)
  • Valneva grew their employee count by -2% last year.

Valneva's People

NameTitleEmail/Phone
1
Head CTM AnalyticsReveal Email/Phone
2
VP QualityReveal Email/Phone
3
Head QAReveal Email/Phone
4
Head Brand and Public Relations UKReveal Email/Phone
5
Head engineeringReveal Email/Phone
6
Head Facility Contamination ControlReveal Email/Phone
7
Head demand, inventory and business operations planningReveal Email/Phone
8
Head Laboratory Animal FacilityReveal Email/Phone
9
VP, Global Head Regulatory Affairs ValnevaReveal Email/Phone
10
VP Human ResourcesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1200M1330-6%$2.4B$8.4B
#2
$69340M1073104%N/A$308.4B
#3
$32820M834497%N/A$182.4B
#4
$11830M803026%$2.7B$83B
Add Company

What Is Valneva?

Valneva is a fully integrated vaccine company that specializes in the development, manufacture and commercialization of innovative vaccines with a mission to protect people from infectious diseases through preventative medicine. The Company seeks financial returns through focused R&D investments in promising product candidates and growing financial contributions from commercial products, striving towards financial self-sustainability.

keywords:N/A

N/A

Total Funding

752

Number of Employees

$109.9M

Revenue (est)

-2%

Employee Growth %

$2B

Valuation

N/A

Accelerator

Valneva News

2022-04-20 - Valneva Provides Regulatory Update on its inactivated COVID ...

Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with...

2022-04-20 - Valneva Shares Fall After EMA Requested More Data on Covid-19 Vaccine

Shares in French pharmaceutical company Valneva SE fell sharply in opening trade Monday after the company said the European Medicines Agency...

2022-04-20 - EU watchdog asks Valneva for more data on COVID shot, shares slump

PARIS (Reuters) -Valneva's shares tumbled on Monday after the French company said The European Medicines Agency (EMA) has asked for more...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$107.4M7670%N/A
#2
$189.2M82513%$197.2M
#3
$219.2M870N/AN/A
#4
$391.6M10366%N/A
#5
$262.2M1070N/AN/A